291 related articles for article (PubMed ID: 32809975)
1. Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs.
Wienke J; Brouwers L; van der Burg LM; Mokry M; Scholman RC; Nikkels PG; van Rijn BB; van Wijk F
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32809975
[TBL] [Abstract][Full Text] [Related]
2. Placental implantation over prior cesarean scar causes activation of fetal regulatory T cells.
Nguyen TA; Kahn DA; Loewendorf AI
Immun Inflamm Dis; 2018 Jun; 6(2):256-263. PubMed ID: 29430878
[TBL] [Abstract][Full Text] [Related]
3. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
[TBL] [Abstract][Full Text] [Related]
4. The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages.
Svensson-Arvelund J; Mehta RB; Lindau R; Mirrasekhian E; Rodriguez-Martinez H; Berg G; Lash GE; Jenmalm MC; Ernerudh J
J Immunol; 2015 Feb; 194(4):1534-44. PubMed ID: 25560409
[TBL] [Abstract][Full Text] [Related]
5. Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface.
Salvany-Celades M; van der Zwan A; Benner M; Setrajcic-Dragos V; Bougleux Gomes HA; Iyer V; Norwitz ER; Strominger JL; Tilburgs T
Cell Rep; 2019 May; 27(9):2537-2547.e5. PubMed ID: 31141680
[TBL] [Abstract][Full Text] [Related]
6. Maternal and fetal factors that contribute to the localization of T regulatory cells during pregnancy.
Wambach CM; Patel SN; Kahn DA
Am J Reprod Immunol; 2014 May; 71(5):391-400. PubMed ID: 24629013
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
[TBL] [Abstract][Full Text] [Related]
8. Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity
Ni D; Tang T; Lu Y; Xu K; Shao Y; Saaoud F; Saredy J; Liu L; Drummer C; Sun Y; Hu W; Lopez-Pastrana J; Luo JJ; Jiang X; Choi ET; Wang H; Yang X
Front Immunol; 2021; 12():678201. PubMed ID: 34084175
[TBL] [Abstract][Full Text] [Related]
9. VIP Promotes Recruitment of Tregs to the Uterine-Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment.
Gallino L; Hauk V; Fernández L; Soczewski E; Gori S; Grasso E; Calo G; Saraco N; Berensztein E; Waschek JA; Pérez Leirós C; Ramhorst R
Front Immunol; 2019; 10():2907. PubMed ID: 31969877
[TBL] [Abstract][Full Text] [Related]
10. Treg programming and therapeutic reprogramming in cancer.
Moreno Ayala MA; Li Z; DuPage M
Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
[TBL] [Abstract][Full Text] [Related]
11. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Origin and Antigenic Specificity of Maternal Regulatory T Cells in Pregnancy.
Ahn SH; Nguyen SL; Petroff MG
Front Immunol; 2020; 11():1302. PubMed ID: 32670288
[TBL] [Abstract][Full Text] [Related]
13. Highly immunosuppressive HLADR
Yang H; Ye S; Goswami S; Li T; Wu J; Cao C; Ma J; Lu B; Pei X; Chen Y; Yu J; Xu H; Qiu L; Afridi S; Xiang L; Zhang X
Int J Cancer; 2020 Apr; 146(7):1993-2006. PubMed ID: 31709528
[TBL] [Abstract][Full Text] [Related]
14. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
15. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation.
Mijnheer G; Lutter L; Mokry M; van der Wal M; Scholman R; Fleskens V; Pandit A; Tao W; Wekking M; Vervoort S; Roberts C; Petrelli A; Peeters JGC; Knijff M; de Roock S; Vastert S; Taams LS; van Loosdregt J; van Wijk F
Nat Commun; 2021 May; 12(1):2710. PubMed ID: 33976194
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and Tumour: The Parallels and Differences in Regulatory T Cells.
Muralidhara P; Sood V; Vinayak Ashok V; Bansal K
Front Immunol; 2022; 13():866937. PubMed ID: 35493450
[TBL] [Abstract][Full Text] [Related]
17. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
[TBL] [Abstract][Full Text] [Related]
18. Abnormal lymphatic vessel development is associated with decreased decidual regulatory T cells in severe preeclampsia.
Jung YJ; Park Y; Kim HS; Lee HJ; Kim YN; Lee J; Kim YH; Maeng YS; Kwon JY
Am J Reprod Immunol; 2018 Jul; 80(1):e12970. PubMed ID: 29756666
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.
De Simone M; Arrigoni A; Rossetti G; Gruarin P; Ranzani V; Politano C; Bonnal RJP; Provasi E; Sarnicola ML; Panzeri I; Moro M; Crosti M; Mazzara S; Vaira V; Bosari S; Palleschi A; Santambrogio L; Bovo G; Zucchini N; Totis M; Gianotti L; Cesana G; Perego RA; Maroni N; Pisani Ceretti A; Opocher E; De Francesco R; Geginat J; Stunnenberg HG; Abrignani S; Pagani M
Immunity; 2016 Nov; 45(5):1135-1147. PubMed ID: 27851914
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
